Premium
COVID‐19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey
Author(s) -
Matucci Andrea,
Caminati Marco,
Vivarelli Emanuele,
Vianello Andrea,
Micheletto Claudio,
Menzella Francesco,
Crisafulli Ernesto,
Passalacqua Giovanni,
Bagnasco Diego,
Lombardi Carlo,
Parronchi Paola,
Crivellaro Mariaangiola A.,
ChiecoBianchi Fulvia,
Rita Marchi Maria,
Guarnieri Gabriella,
Cosmi Lorenzo,
Rossi Oliviero,
Almerigogna Fabio,
Senna Gianenrico,
Vultaggio Alessandra
Publication year - 2021
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14516
Subject(s) - covid-19 , medicine , multicenter study , inflammation , intensive care medicine , immunology , virology , randomized controlled trial , disease , outbreak , infectious disease (medical specialty)